I am/have/had
I am looking for
Advanced Filters
Found 41 clinical trials
Cardiovascular Complications of Carfilzomib
Cardiovascular toxicity of carfilzomib, a last generation proteasome inhibitor, is highly incident according to retrospective data. Prospective cohort study of patients initiated on carfilzomib.
proteasome inhibitor
cardiovascular complications
carfilzomib
- 0 views
- 05 Aug, 2020